2,911.90
+5.21
+(0.18%)
At close: March 3 at 1:58:59 PM CST
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 9 | 9 | 16 | 15 |
Avg. Estimate | 4.88B | 4.83B | 19.47B | 19.96B |
Low Estimate | 4.79B | 4.8B | 19.28B | 19.71B |
High Estimate | 4.96B | 4.86B | 19.86B | 20.24B |
Year Ago Sales | 5.15B | 5.03B | 20.06B | 19.47B |
Sales Growth (year/est) | -5.20% | -3.95% | -2.91% | 2.50% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
KMB.MX | -- | -- | -- | -- |
S&P 500 | 6.43% | 6.13% | 9.43% | 14.26% |
Upgrades & Downgrades
Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 3/28/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 3/27/2025 |
Reiterates | Piper Sandler: Overweight to Overweight | 1/29/2025 |
Maintains | UBS: Neutral to Neutral | 1/29/2025 |
Reiterates | RBC Capital: Outperform to Outperform | 1/24/2025 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 1/17/2025 |